Various types of neurological disorders affect millions of people around the world, including 24 million that suffer from Alzheimer’s disease. Moreover, as human life expectancy increases at an ever-faster rate, the probability of being affected by dementia rises. With the failures of the healthcare system to provide
at-home neurorecovery solutions,
which would provide accessibility to those unable to easily commute to receive in-person therapy; Ixtlan Bioscience is focused on developing its novel and proprietary Ixtlan AD Kit, for the at-home treatment of patients suffering from Alzheimer’s and dementia diseases.
Dementia in numbers